Patients enrolled in the trials should be well balanced according to existing prognostic scores.
Raleigh, NC (PRWEB)
January 29, 2017
A newly-published article suggests there there is little good data on the effectiveness of second-line treatment in patients with recurrent pleural mesothelioma. Surviving Mesothelioma has the details on its website. Click here to read the full article.
The article written by a trio of doctors from England and Italy points to what the authors see as flaws and weaknesses in previous second-line mesothelioma treatment studies and calls for better-designed studies in the future.